Posterior Uveitis

14 registered clinical trials studyying Posterior Uveitis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Intravitreal Sirolimus as Therapeutic Approach to Uveitis NCT01280669	Stanford University	Phase 2
Unknown	Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infec NCT04126850	Fakultas Kedokteran Universitas Indonesia	—
Completed	Dexamethasone Intravitreal Implant (Ozurdex®) for Recurrent Vogt-Koyanagi-Harada (VKH) Disease Posterior Uveit NCT03971279	Benha University	—
Completed	Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients NCT02764697	Tampa Bay Uveitis Center, LLC	Phase 4
Completed	Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis NCT02746991	EyePoint Pharmaceuticals, Inc.	Phase 3
Unknown	Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The NCT01717170	University of Nebraska	Phase 1 / Phase 2
Completed	Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis NCT01789320	Clearside Biomedical, Inc.	Phase 1 / Phase 2
Completed	Sirolimus as Therapeutic Approach to Uveitis NCT00908466	Johns Hopkins University	Phase 1
Completed	Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis NCT00615693	Novartis	Phase 2
Completed	Retisert and Cataract Surgery in Patients With Severe Uveitis NCT00570830	Duke University	N/A
Unknown	Quality of Life and Visual Function in Uveitis Patients NCT00407316	The New York Eye & Ear Infirmary	—
Completed	A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis NCT00333814	Allergan	Phase 2 / Phase 3
Recruiting	Birdshot Chorioretinopathy : Prospective Follow-up and Immunogenetic Studies(CO-BIRD) NCT05153057	Assistance Publique - Hôpitaux de Paris	—
Completed	Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB) NCT00167583	University Hospital Tuebingen	Phase 3